No Result

View All Result

No products in the cart.

Home The 2MM Team

#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)

byKathleen Lau

December 25, 2020

in The 2MM Team

Reading Time: 1 min read

Check out the original article from the Lancet Haematology here.

RELATED REPORTS

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

Yartemlea (narsoplimab-wuug) improves platelets hemolysis organ function hematopoietic stem cell transplant–associated thrombotic microangiopathy transplant patients

2 Minute Medicine Rewind

COVID-19 susceptibility may be increased in patients with hematological malignancies compared to solid organ tumours

RelatedReports

AI Roundup

2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]

January 19, 2026

Engineered stem cells mitigate liver damage caused by radiation [PreClinical]

All Specialties

Yartemlea (narsoplimab-wuug) improves platelets hemolysis organ function hematopoietic stem cell transplant–associated thrombotic microangiopathy transplant patients

January 15, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Adding azithromycin to hydroxychloroquine does not improve clinical outcomes in COVID-19 patients

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Regular screening of asymptomatic SARS-CoV-2 carriers may limit COVID-19 transmission

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result